Unsuspected rejection episodes on routine surveillance endomyocardial biopsy post-heart transplant in paediatric patients

Pediatric Transplantation

Volumn 11, Issue 3, 2007, Pages 286-290

  Dixon, Viktoria ^a   Macauley, Chloe ^a   Burch, Michael ^a   Sebire, Neil J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Childhood; Endomyocardial biopsy; Rejection; Transplant

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; BARTH SYNDROME; CARDIAC GRAFT REJECTION; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEWBORN; PATIENT MONITORING; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; SYMPTOMATOLOGY;

ADOLESCENT; BIOPSY; CHILD; CHILD, PRESCHOOL; ENDOCARDIUM; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MYOCARDIUM; RETROSPECTIVE STUDIES;

EID: 34147139410     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00650.x     Document Type: Article

References (24)

1. BOUCEK MM, WALTZ DA, EDWARDS LB, et al. The Registry of the International Society for Heart and Lung Transplantation: 9th official Pediatric Heart Transplantation Report-2006. J Heart Lung Transplant 2006: 25: 893-903.
2. GRIMM M, RINALDI M, YONAN NA, et al. Superior prevention of acute rejection by tacrolimus vs ciclosporin in heart transplant recipients - a large European trial. Am J Transplant 2006: 6: 1387-1397.
3. KOBASHIGAWA JA, MILLER LW, RUSSELL SD, et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporin with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006: 6: 1377-1386.
4. ASANTE-KORANG A, BOYLE GJ, WEBBER SA, MILLER SA, FRICKER SJ. Experience of FK506 immunosuppression in paediatric heart transplantation: A study of long-term adverse effects. J Heart Lung Transplant 1996: 15: 415-422.
5. WINTERS GL. The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection. Curr Opin Cardiol 1997: 12: 146-152.
6. BOUCEK MM. Surveillance endomyocardial biopsy in paediatric heart transplantation: Fashion or foible? Pediatr Transplantation 2000: 4: 173-176.
7. HSU DT. Can non-invasive methodology predict rejection and either dictate or obviate the need for an endomyocardial biopsy in pediatric heart transplant recipients? Pediatr Transplantation 2005: 9: 697-699.
8. GRADEK WQ, D'AMICO C, SMITH AL, VEGA D, BOOK WM. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation. J Heart Lung Transplant 2001: 20: 497-502.
9. KUHN MA, DEMING DD, CEPHUS CE, et al. Moderate acute rejection detected during annual catheterization in paediatric heart recipients. J Heart Lung Transplant 2003: 22: 276-280.
10. WHITE JA, GUIRAUDON C, PFLUGFELDER PW, KOSUK WJ. Routine surveillance myocardial biopsies are unnecessary beyond 1 year after heart transplantation. J Heart Lung Transplant 1995: 14: 1052-1056.
11. WAGNER K, OLIVER MC, BOYLE GJ, et al. Endomyocardial biopsy in pediatric heart transplant recipients: A useful exercise? Pediatr Transplantation 2000: 4: 186-192.
12. LEVI DS, DECONDE AS, FISHBEIN MC, BURCH C, ALEJOS JC, WETZEL GT. The yield of surveillance endomyocardial biopsies as a screen for cellular rejection in pediatric heart transplant. Pediatr Transplantation 2004: 8: 1-2.
13. STEWART S, WINTERS GL, FISHBEIN MC, et al. Revision of the 1990 working formulation for the standardization of the nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005: 24: 1710-1720.
14. FISHBEIN MC KOBASHIGAWA J. Biopsy negative transplant rejection: Etiology, diagnosis and therapy. Curr Opin Cardiol 2004: 19: 166-169.
15. SISSON S, JAZZAR A, MISCHKE L, COOPER DK, ZUHDI N. How many endomyocardial biopsies are necessary in the first year after heart transplantation? Transpl Int 1996: 9: 243-247.
16. BRAUNLIN EA, SHUMWAY SJ, BOLMAN RM, et al. Usefulness of surveillance endomyocardial biopsy after pediatric cardiac transplantation. Clin Transplant 1998: 12: 184-189.
17. SETHI GK, KOSARAJU S, ARABIA FA, ROASDO LJ, MCCARTHY MS, COPELAND JG. Is it necessary to perform surveillance endomyocardial biopsies in heart transplant recipients? J Heart Lung Transplant 1995: 14: 1047-1051.
18. ZALES VR, CRAWFORD S, BACKER CL, et al. Role of endomyocardial biopsy in rejection surveillance after heart transplantation in neonates and children. J Am Coll Cardiol 1994: 23: 766-771.
19. PAHLE E, NAFTEL DC, CANTER CE, FRAZIER EA, KIRKLAN JK, MORROW R for the Pediatric Heart Transplant Study Group. Death after rejection with severe hemodynamic compromise in paediatric recipients. J Heart Lung Transplant 2001: 30: 279-287.
20. EISENBERG MS, CHAN HJ, WARSHOFSKY MK. Elevated levels of plasma CRP are associated with decreased graft survival in cardiac transplant recipients. Circulation 2000: 102: 2100-2104.
21. GULLESTAD L, SIMONSEN S, UELAND T. Possible role of proinflammatory cytokines in heart allograft coronary artery disease. Am J Cardiol 1999: 84: 999-1003.
22. CHIN C, AKHTAR MJ, ROSENTHAL DN, BERNSTEIN D. Safety and utility of routine surveillance biopsy in paediatric patients after heart transplantation. J Pediatr 2000: 136: 238-242.
23. POPHAL SG, SIGFUSSON G, BOOTH KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999: 34: 2105-2110.
24. DENG MC, EISEN HJ, MEHRA MR. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006: 6: 150-160.